Steep Jump in Gabapentinoid Use Among US Patients With Cancer Steep Jump in Gabapentinoid Use Among US Patients With Cancer

The use of gabapentin and pregabalin doubled between 2005 and 2015 among US patients with cancer; experts say these drugs may be appropriate, but warn about adverse effects and potential for abuse.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news